Primary Biliary Cholangitis Trial, Recruiting (NCT05151809)

Primary Biliary Cholangitis Trial, Recruiting NCT05151809 Sponsor: University of Milano Bicocca Condition: Primary Biliary Cholangitis

Printed from Voxsanity (voxsanity.com.au) — NCT05151809 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Primary Biliary Cholangitis

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are at least 18 years old and currently live in Italy
You have been diagnosed with Primary Biliary Cholangitis (PBC), which is confirmed by meeting at least 2 of the following 3 conditions:
Your blood tests show higher than normal levels of certain liver enzymes called alkaline phosphatase and/or GGT
A blood test has found specific antibodies related to PBC (called anti-mitochondrial antibodies at a level of 1:40 or higher, or specific antinuclear antibodies known as gp-210 or sp100)
A liver tissue sample (biopsy) has shown specific changes in the bile ducts that are typical of PBC

Who may not be able to join:

You have clearly stated that you do not wish to take part in the study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +39 039 233 2187

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05151809

Sponsor: University of Milano Bicocca

Phase: Not Applicable

Status: Recruiting

Condition: Primary Biliary Cholangitis

Trial contact: +39 039 233 2187

More information: https://clinicaltrials.gov/study/NCT05151809

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are at least 18 years old and currently live in Italy
You have been diagnosed with Primary Biliary Cholangitis (PBC), which is confirmed by meeting at least 2 of the following 3 conditions:
Your blood tests show higher than normal levels of certain liver enzymes called alkaline phosphatase and/or GGT
A blood test has found specific antibodies related to PBC (called anti-mitochondrial antibodies at a level of 1:40 or higher, or specific antinuclear antibodies known as gp-210 or sp100)
A liver tissue sample (biopsy) has shown specific changes in the bile ducts that are typical of PBC

Who may not be able to join:

You have clearly stated that you do not wish to take part in the study

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University of Milano Bicocca

Registry

ClinicalTrials.gov

Start date

19 September 2019

Est. completion

24 January 2029

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

Phenotypes and sub-phenotypes of PBC Italian patients

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov